“…Concerning the potential usefulness of TTP to guide antimicrobial therapy, most works have addressed onco-haematological patients with febrile neutropenia [2,3], probably because these patients combine a high risk of antimicrobial selective pressure with a high risk of bloodstream infection. In this issue, Puerta-Alcade et al advocate, based on a retrospective study, early deescalation at 24 h [2] instead of 48e96 h as commonly advised because (i) the great majority of episodes with positive blood culture are positive within the first 24 h, (ii) positive episodes with TTP 24 h are commonly optimally treated infections, catheter-related infections, or infections caused by slowly growing microorganisms such as Candida or anaerobic Gram-negative bacteria, and (iii) growth of multidrug-resistant Gram-negative bacilli is exceptional beyond 24 h. With similar logistics, other studies show short TTP in agreement with Puerta-Alcade et al's results: median TTP, although it varied between bacterial groups, was 24 h except for yeasts (see ref.…”